Cause of death, by non-communicable diseases, ages 0-4, male in Czechia
Czechia: Cause of death, by non-communicable diseases, ages 0-4, male was 34.4% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 0-4, male in Czechia, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 0-4.
Analysis
Czechia recorded 34.4% for cause of death, by non-communicable diseases, ages 0-4, male in 2021.
The figure is up 5.9% on the previous year and up 1.1% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, male in Czechia peaked at 37.5% in 2015 and was at its lowest, 32.5%, in 2020.
That places Czechia 77th out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 0-4, male in Czechia, year by year
| Year | % of total male deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 33.0% | — |
| 2010 | 34.0% | +3.2% |
| 2015 | 37.5% | +10.2% |
| 2019 | 33.1% | -11.8% |
| 2020 | 32.5% | -1.8% |
| 2021 | 34.4% | +5.9% |
Czechia compared with similar countries
- Czechia's 34.4% is below the median for high income countries, which is 43.2%, 80% of the median. (58 countries reporting)
- Czechia's 34.4% is below the median for Europe & Central Asia, which is 39.3%, 87% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 33.0% | 33.0% | 33.0% | 1 |
| 2010s | 34.8% | 33.1% | 37.5% | 3 |
| 2020s | 33.4% | 32.5% | 34.4% | 2 |
Countries ranked near Czechia
More health data for Czechia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.7726 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,169 deaths per 1,000 people (2090)
- Number of infants who die before age 1 34 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.76 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0222 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.46 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, male in Czechia?
- Cause of death, by non-communicable diseases, ages 0-4, male in Czechia was 34.4% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, male recorded in Czechia?
- The highest recorded value was 37.5% in 2015.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, male recorded in Czechia?
- The lowest recorded value was 32.5% in 2020.
- How does Czechia rank for cause of death, by non-communicable diseases, ages 0-4, male?
- Czechia ranks 77th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, male rising or falling in Czechia?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is flat.
- Where does this Czechia data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.